Search Results - Elke Valk

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    CTLA-4 activation of phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death. by Helga Schneider, Elke Valk, Rufina Leung, Christopher E Rudd

    Published in PLoS ONE (2008-01-01)
    Get full text
    Article


  2. 2

    Correction: CTLA-4 Activation of Phosphatidylinositol 3-Kinase (PI 3-K) and Protein Kinase B (PKB/AKT) Sustains T-Cell Anergy without Cell Death. by Helga Schneider, Elke Valk, Rufina Leung, Christopher E. Rudd

    Published in PLoS ONE (2009-01-01)
    Get full text
    Article


  3. 3

    Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma by Julia Wendler, Richard I. Lewis, Alexandra Kutilina, Markus Knott, Lisa Kristina Isbell, Elke Valk, Peter Borchmann, Jan-Michel Heger, Gerald Illerhaus, Elisabeth Schorb

    Published in Haematologica (2025-01-01)
    Get full text
    Article


  4. 4

    Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma... by Lisa K Isbell, Roswitha Uibeleisen, Alexander Friedl, Elvira Burger, Tatja Dopatka, Florian Scherer, Andras Orban, Eliza Lauer, Natalie Malenica, Inna Semenova, Annika Vreden, Elke Valk, Julia Wendler, Simone Neumaier, Heidi Fricker, Abed Al Hadi El Rabih, Cora Gloggengießer, Daniela Hilbig, Sabine Bleul, Joachim Weis, Dennis Gmehlin, Matthias Backenstrass, Sebastian Wirtz, Gabriele Ihorst, Jürgen Finke, Gerald Illerhaus, Elisabeth Schorb

    Published in BMC Cancer (2023-08-01)
    Get full text
    Article


Search Tools: